Paricalcitol for reduction of albuminuria in diabetes

Lancet. 2011 Feb 19;377(9766):635-6, author reply 636-7. doi: 10.1016/S0140-6736(11)60224-9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Albuminuria / drug therapy*
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Diabetic Nephropathies / drug therapy*
  • Dose-Response Relationship, Drug
  • Ergocalciferols / adverse effects
  • Ergocalciferols / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic
  • Vitamin D Deficiency / drug therapy

Substances

  • Bone Density Conservation Agents
  • Ergocalciferols
  • paricalcitol